AMSTERDAM and TEANECK, N.J., July 8,
2021 /PRNewswire/ -- Royal
Philips (NYSE: PHG, AEX: PHIA), a global leader in
health technology, and Cognizant (Nasdaq: CTSH), a
world-leading professional services firm, today announced a new
collaboration to develop end-to-end digital health solutions that
will enable healthcare organizations and life sciences companies to
improve patient care and accelerate clinical trials. The strategic
alliance brings together Philips HealthSuite, a cloud-based
platform and Cognizant's digital engineering expertise to deliver
and maintain leading-edge digital health solutions at scale,
providing advanced connectivity and using big data to create
actionable insights.
Philips HealthSuite, built on Amazon Web Services, is an
integrated, modular set of standards-based capabilities that
support the development of digital health propositions. The
platform securely stores critical healthcare data and provides
both advanced data analytics and AI capabilities, while
delivering industry-leading interoperability, connectivity, and
regulatory compliance. To date, more than 100 types of medical
devices have been integrated into HealthSuite, with over 145
billion clinical images securely archived on the cloud
platform.
As part of this collaboration, Cognizant will build, deploy,
implement, and operate client-specific applications on Philips
HealthSuite. These customizable, scalable solutions integrate
advanced data analytics, helping to improve both the
patient and clinician experience by providing relevant data to the
appropriate point-of-care.
With these solutions, healthcare providers can monitor their
patients outside traditional clinical settings, and patients can
stay more informed of their own well-being. In addition, both
biopharmaceutical and medical device manufacturers can quickly gain
actionable insights through advanced analytics to make more
informed clinical development decisions and rapidly bring new
solutions to patients.
"Despite advances, patients and clinicians still face a
fragmented technology and data landscape that holds back innovative
healthcare services which improve care quality and the human
experience," said Shez Partovi,
Chief Innovation & Strategy Officer, Royal Philips. "Philips is committed to driving
the digital transformation of healthcare. Partnering with
Cognizant's experienced digital engineering teams will accelerate
the adoption of solutions built on Philips HealthSuite, delivering
digital solutions across the healthcare continuum in a secure and
compliant manner, and ultimately helping guide better health
decisions for patients."
For Life Sciences companies, Philips HealthSuite's compliant and
secure medical device connectivity, data integration, and analysis
will also benefit remote patient monitoring and decentralized
clinical trials. This will enable a reduction in paperwork,
help researchers reach more diverse trial participants, and
improve connectivity between investigators and participants –
with the goal of improving the quality and speed of therapy
development.
"Cognizant and Philips are each dedicated to improving
people's lives through health technology," said Ursula Morgenstern, President of Global Growth
Markets at Cognizant. "This new collaboration will provide
critical solutions that help manage the growing amount of
health data available, keep patients and providers
better connected, and help accelerate life-saving
therapies to market. Virtual and digital health solutions are
fundamental to improving health awareness and engagement.
We are proud to work with Philips, a world leader in
healthtech, to support the health and well-being of people
everywhere."
Learn More:
- Philips HealthSuite
- Cognizant Life Sciences
About Royal
Philips
Royal Philips
(NYSE: PHG, AEX: PHIA) is a leading health technology company
focused on improving people's health and well-being, and enabling
better outcomes across the health continuum – from healthy living
and prevention, to diagnosis, treatment and home care. Philips
leverages advanced technology and deep clinical and consumer
insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 77,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
About Cognizant
Cognizant (Nasdaq-100: CTSH) is one of
the world's leading professional services companies, transforming
clients' business, operating and technology models for the digital
era. Our unique industry-based, consultative approach helps clients
envision, build and run more innovative and efficient businesses.
Headquartered in the US, Cognizant is ranked 185 on the Fortune 500
and is consistently listed among the most admired companies in the
world. Learn how Cognizant helps clients lead with digital at
www.cognizant.com or follow us @Cognizant.
For further
information, contact:
|
|
|
|
Cognizant
(US):
|
Cognizant (Europe,
Asia-Pac):
|
Cognizant
(India):
|
Josh
Blumenthal
|
Christina
Schneider
|
Rashmi
Vasisht
|
joshua.blumenthal@cognizant.com
|
christina.schneider@cognizant.com
|
rashmi.vasisht@cognizant.com
|
|
|
|
Philips Global Press
Office
|
|
|
Mark
Groves
|
|
|
mark.groves@philips.com
|
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/philips-and-cognizant-collaborate-to-introduce-digital-health-solutions-to-providers-researchers-and-patients-301327488.html
SOURCE Cognizant